Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Fatty Liver × Other × Clear all

Phase

Phase NA 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Gastrointestinal 1

Conditions

Obesity 193 Neoplasms 69 Breast Neoplasms 61 Overweight 58 Sexual Dysfunction, Physiological 43 Polycystic Ovary Syndrome 39 Motor Activity 38 Weight Loss 27 Mucositis 26 Dyspnea 26 Prostatic Neoplasms 21 Sedentary Behavior 13 Multiple Endocrine Neoplasia Type 1 13 Lung Neoplasms 13 Sexual Dysfunctions, Psychological 12 Depression 12 Constipation 12 Anxiety Disorders 12 Endometrial Neoplasms 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Pain 10 Diabetes Mellitus, Type 2 10 Diabetes Mellitus 10 Sexuality 9 Head and Neck Neoplasms 9 Colorectal Neoplasms 9 Cardiovascular Diseases 9 Pulmonary Disease, Chronic Obstructive 8 Infertility 8 Fatigue 8

Interventions

Excitatory Amino Acids 1 Amino Acids, Essential 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03717935 2025-03-24

ORANGE

University of Colorado, Denver

Phase NA Completed

27 enrolled 15 charts

Fatty Liver, Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡